Stephen Albert Johnston

USPTO Granted Patents = 54 (Patent Applications = 36)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 2.1

ph-index = 12

Forward Citations = 864(Granted Patents)

Forward Citations (Not Self Cited) = 710(Dec 10, 2025)

Location History:

Durham, NC (US) (1993 - 2002)
Dallas, TX (US) (1996 - 2013)
Temple, AZ (US) (2017)
Tempe, AZ (US) (2009 - 2024)

Company Filing History:

25 out of 1,736

Arizona State University

patents

17 out of 5,452

The University of Texas System

patents

4 out of 1,521

Cornell Research Foundation Inc.

E.i. Dupont De Nemours and Company

Arizona Board of Regents, a Body Corporate

patents

10. 1 out of 470

Colorado State University Research Foundation

patents

11. 1 out of 1

Whittemore Peterson Institute

13. 4 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2024

Loading Chart...

Areas of Expertise:

Immunotherapy

Neoantigens

Canine Cancer Vaccines

Bacterial Infections

Novopeptides

Synthetic Antibodies

Polypeptides

Genetic Vaccines

Immune Response

Protein Cross-Linking

Chronic Fatigue Syndrome

MALDI-Based Quality Control

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12025615 - Methods of classifying response to immunotherapy for cancer (2024-07-02),

2. 12018252 - Methods and compositions for identifying neoantigens for use in treating cancer (2024-06-25),

3. 11976274 - Methods and compositions for identifying neoantigens for use in treating and preventing cancer (2024-05-07),

4. 11971410 - Methods of classifying response to immunotherapy for cancer (2024-04-30),

5. 11484581 - Method to create personalized canine cancer vaccines (2022-11-01),

6. 11360086 - Diagnostic to distinguish bacterial infections (2022-06-14),

7. 11168121 - Identification and use of novopeptides for the treatment of cancer (2021-11-09),

8. 11067582 - Peptide array quality control (2021-07-20),

9. 10900975 - Systems and methods of epitope binning and antibody profiling (2021-01-26),

10. 10712342 - Diagnostic to distinguish bacterial infections (2020-07-14),

11. 10578623 - Peptide array quality control (2020-03-03),

12. 10422793 - Compound arrays for sample profiling (2019-09-24),

13. 10416174 - Diagnosis and prognosis for chronic fatigue syndrome (2019-09-17),

14. 10126300 - Immunosignature based diagnosis and characterization of canine lymphoma (2018-11-13),

15. 10125167 - Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics (2018-11-13),

Title: The Innovative Journey of Stephen Albert Johnston

Introduction: Stephen Albert Johnston, a distinguished inventor hailing from Temple, Arizona, has made significant contributions to the field of innovation through his groundbreaking work in various technological domains.

Latest Patents: Johnston's latest patents showcase his prowess in developing cutting-edge solutions for complex problems, highlighting his commitment to pushing the boundaries of technology.

Career Highlights: With a career spanning several decades, Johnston has amassed a remarkable portfolio of inventions that have revolutionized industries ranging from biotechnology to information technology. His keen insight and relentless drive for innovation have earned him a reputation as a trailblazer in the world of inventors.

Collaborations: Throughout his career, Johnston has collaborated with leading research institutions, universities, and companies to bring his visionary ideas to life. His ability to work seamlessly with multidisciplinary teams has led to the successful development and commercialization of numerous groundbreaking technologies.

Conclusion: Stephen Albert Johnston's unwavering dedication to innovation, coupled with his exceptional talent for problem-solving, has solidified his position as a pioneering inventor whose work continues to shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.